Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tennr›
Analysis
AddedApr 27, 2023
UpdatedJun 26, 2026
Tennr

Tennr

Series C

Tennr: Automating healthcare ops with AI for growth & efficiency.

HQ
New York City, NY, US
Founded
2021
Accelerator
Y Combinator logoY CombinatorW23
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Products & Services
  2. 02Competitive Risks
  3. 03Pricing Strategy
  1. 01Products & Services
  2. 02Competitive Risks
  3. 03Pricing Strategy

Product Overview

Tennr is an agentic patient orchestration platform built for policy-grade decisioning and patient flow at scale. It processes referrals from fax, email, or e-portal using RaeLM, a proprietary vision-language model trained on over 100 million healthcare documents and 8,000 payer criteria sets.

The platform automates document intake, eligibility verification, prior authorization, and patient routing. Tennr Network provides real-time visibility into referral status for referring providers, receiving providers, and patients.

Competitive Disadvantages

Tennr focuses on a narrow but critical wedge in healthcare: the unstructured document intake problem for referral-based care. Unlike competitors who require EMR rip-outs or workflow changes, Tennr integrates with existing fax, email, and portal systems. The company's proprietary RaeLM model is trained specifically on healthcare payer criteria and medical documentation, giving it a specialized moat against general-purpose LLMs.

However, the company faces competition from broader healthcare automation platforms and emerging AI entrants. The narrow product focus on referral processing could limit expansion if competitors bundle similar capabilities into broader practice management suites. Tennr's rapid growth suggests strong product-market fit, but sustaining differentiation will depend on continued model training and network effects from the Tennr Network.

Pricing Strategy

Tennr operates on a SaaS subscription model targeting healthcare providers, health systems, and national networks. The platform charges on a recurring basis for access to its AI-powered document intelligence and patient orchestration tools.

Pricing scales with document volume and number of providers, reflecting the company's enterprise healthcare focus. The company has more than tripled its revenue since its Series B round just two quarters prior.